Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

Completed · Phase 2

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC™ Model.

Key facts

Study ID

NCT01134328

Run by

Aciex Therapeutics, Inc.

People needed

83

Starts

2010-05-01

Expected to finish

2010-07-01

Last updated by the study team

2017-09-14

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Positive bilateral conjunctival allergen challenge(CAC) reaction

You may not qualify if…

• Known contraindications or sensitivities to the study medication or its components.
• Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters.
• Use of disallowed medications during the period indicated prior to study enrollment or during the study.

Where it is running

• Ora, Inc — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.